Abstract:Adverse experiences during pregnancy induce placental programming, affecting the fetus and its developmental trajectory. However, the influence of 'positive' maternal experiences on the placenta and fetus remain unclear. In animal models of early life stress, environmental enrichment (EE) has ameliorated and even prevented associated impairments in brain and behavior. Here, using a maternal immune activation (MIA) model in rats, we test whether EE attenuates maternal, placental and/or fetal responses to an inflammatory challenge, thereby offering a mechanism by which fetal programming may be prevented. Moreover, we evaluate life-long EE exposure on offspring development and examine a constellation of genes and epigenetic writers that may protect against MIA challenges. In our model, maternal plasma corticosterone and interleukin-1β were elevated 3 h after MIA, validating the maternal inflammatory response. Evidence for developmental programming was demonstrated by a simultaneous decrease in the placental enzymes Hsd11b2 and Hsd11b2/Hsd11b1, suggesting disturbances in glucocorticoid metabolism. Reductions of Hsd11b2 in response to challenge is thought to result in excess glucocorticoid exposure to the fetus and altered glucocorticoid receptor expression, increasing susceptibility to behavioral impairments later in life. The placental, but not maternal, glucocorticoid implications of MIA were attenuated by EE. There were also sustained changes in epigenetic writers in both placenta and fetal brain as a consequence of environmental experience and sex. Following MIA, both male and female juvenile animals were impaired in social discrimination ability. Life-long EE mitigated these impairments, in addition to the sex specific MIA associated disruptions in central Fkbp5 and Oprm1. These data provide the first evidence that EE protects placental functioning during stressor exposure, underscoring the importance of addressing maternal health and well-being throughout pregnancy. Future work must evaluate critical periods of EE use to determine if postnatal EE experience is necessary, or if prenatal exposure alone is sufficient to confer protection.

Placental programming of neuropsychiatric disease

Maternal immune activation and role of placenta in the prenatal programming of neurodevelopmental disorders

Placental Pathology and the Developing Brain

Epigenetic Regulation of Infant Neurobehavioral Outcomes

Placental dysfunction: The core mechanism for poor neurodevelopmental outcomes in the offspring of preeclampsia pregnancies

What is known about neuroplacentology in fetal growth restriction and in preterm infants: A narrative review of literature

Prenatal origins of neuropsychiatric diseases

Placental genomic risk scores and early neurodevelopmental outcomes

Placental Epigenome Impacts Fetal Development: Effects of Maternal Nutrients and Gut Microbiota

Impaired Interneuron Development in a Novel Model of Neonatal Brain Injury

Environmental influences on placental programming and offspring outcomes following maternal immune activation

The Long and the Short of it: Gene and Environment Interactions During Early Cortical Development and Consequences for Long-Term Neurological Disease

Prenatal Programming of Neuroendocrine System Development by Lipopolysaccharide: Long-Term Effects

Glucocorticoids, prenatal stress and the programming of disease

Neonatal Encephalopathy is a Complex Phenotype Representing Reproductive and Pregnancy Exposome Effects on the Maternal-Placental-Fetal Triad

Recent Insights and Interventional Approaches

Prenatal glucocorticoids and long-term programming

Advancing our knowledge of placental function and how it relates to the developing fetal brain

Pathogenic Infections during Pregnancy and the Consequences for Fetal Brain Development

Adverse neuropsychiatric development following perinatal brain injury: from a preclinical perspective

Maternal Diabetes and Fetal Programming Toward Neurological Diseases: Beyond Neural Tube Defects